A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.
Lee IJ, Lan YH, Wu PY, Wu YW, Chen YH, Tseng SC, Kuo TJ, Sun CP, Jan JT, Ma HH, Liao CC, Liang JJ, Ko HY, Chang CS, Liu WC, Ko YA, Chen YH, Sie ZL, Tsung SI, Lin YL, Wang IH, Tao MH.
Lee IJ, et al. Among authors: wu yw, wu py.
Emerg Microbes Infect. 2023 Dec;12(1):2149353. doi: 10.1080/22221751.2022.2149353.
Emerg Microbes Infect. 2023.
PMID: 36395071
Free PMC article.